Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) (NWG) vs Smith & Nephew plc (SNN) Price & Performance

NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)Trade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) vs Smith & Nephew plc — how do they compare? NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) trades at $17.13 (market cap $66.98B), while Smith & Nephew plc trades at $27.21 (market cap $11.10B). The key difference: NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) is far larger — about 6× Smith & Nephew plc's market cap, and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) pays the higher dividend (5.5%). Which is the better fit depends on your goals — on Pluang, investors hold NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) for 1 Days and Smith & Nephew plc for 121 Days on average.

NWGSNN
Market Cap
$66.98B$11.10B
Volume
5,259,0601,051,703
Sector
FinancialsHealth
52-Week High
$19.42$37.17
52-Week Low
$13.89$26.42
Typical Hold Time
1 Days121 Days
Enterprise Value
$140.55B$14.13B
Dividend Yield
5.5%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)

No Aura AI signal available yet.

Smith & Nephew plc

SNN trades at $27.10, near its 52-week low, with a bearish technical signal. The company reported solid fundamentals with revenue growth to $6.16B in 2025 and a net income margin of 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. Cash flow from operations remains strong at $1.29B, though net cash flow was negative $64M in 2025.

The outlook is mixed: strong profitability and innovation support long-term value, but near-term headwinds include analyst downgrades and competitive pressures. Risks involve execution challenges and market sentiment. The stock presents a cautious opportunity for value investors, balancing solid fundamentals against current bearish trends.

Returns comparison

Trailing returns across standard periods

About NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)

NatWest Group is a UK banking company serving personal, business, and institutional customers. Its services include deposits, lending, payments, and wealth management.

Read more on NWG →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →